Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 6 Neoplasm Metastasis 6 Pancreatic Neoplasms 2 Lung Neoplasms 1 Lung Diseases 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

Paclitaxel 47 Carboplatin 38 liposomal doxorubicin 25 Bevacizumab 23 Gemcitabine 18 Topotecan 15 pembrolizumab 14 mirvetuximab soravtansine 11 rucaparib 8 niraparib 7 Cisplatin 7 1-dodecylpyridoxal 7 trebananib 6 Drug Therapy 6 130-nm albumin-bound paclitaxel 6 Nivolumab 5 Cyclophosphamide 5 cemiplimab 4 sarilumab 3 relacorilant 3 pazopanib 3 oregovomab 3 olaparib 3 Doxorubicin 3 Docetaxel 3 Albumin-Bound Paclitaxel 3 tocilizumab 2 seribantumab 2 phenoxodiol 2 pegfilgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Fallopian Tube Neoplasms × demcizumab × Clear all

NCT01952249 2020-09-09

SIERRA

Mereo BioPharma

Phase 1 Terminated

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡